News
Truist Securities Maintains Buy Rating for PROCEPT BioRobotics: Here's What You Need To Know
28 Feb 24
Analyst Ratings
Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $58
28 Feb 24
News, Price Target, Analyst Ratings
PROCEPT BioRobotics Projects Full Year 2024 Revenue To Be Approximately $210M, Est $204.458M
27 Feb 24
News, Guidance
PROCEPT BioRobotics: Q4 Earnings Insights
27 Feb 24
Earnings
PROCEPT BioRobotics Q4 2023 GAAP EPS $(0.54) Misses $(0.44) Estimate, Sales $43.58M Beat $42.06M Estimate
27 Feb 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
PROCEPT BioRobotics's Earnings: A Preview
26 Feb 24
Earnings
Press releases
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
4 Apr 24
News, Press Releases
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
2 Apr 24
News, Press Releases
Revolutionizing Medical Histories: Treatment AI's (CSE: TRUE) Pioneering Approach to Culturally Sensitive Data Collection
2 Apr 24
News, Press Releases
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
27 Feb 24
Earnings, Press Releases
CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors
8 Feb 24
News, Management, Press Releases